Belt da Hanya: Haɗin kai, Jituwa da Win-Win
samfurori

Kayayyaki

Tofacitinib CAS: 477600-75-2 Mai Bayar da Manufacturer

Tofacitinib shine farkon ƙananan ƙwayoyin ƙwayoyin kinase inhibitor wanda aka amince da shi don maganin RA.Tofacitinib shi ne mai hanawa na nau'i-nau'i hudu na Janus kinase (JAK): JAK1, JAK2, JAK3, da Tyk2.Tofacitinib yana aiki ta hanyar hana phosphorylation da kunna masu fassarar sigina da masu kunnawa na rubutun (STATs), don haka yana hana samar da masu watsa labaru masu kumburi. a cikin haɗin gwiwa nama.


Cikakken Bayani

Tags samfurin

Aikace-aikace da Tasiri

Tofacitinib magani ne don maganin rheumatoid amosanin gabbai (RA), psoriasis, cututtukan hanji mai kumburi, da sauran cututtuka na rigakafi, da kuma rigakafin ƙin yarda da dashen gabobin.Yana da mai hana enzyme Janus kinase 3 (JAK3), wanda ke nufin cewa yana tsoma baki tare da hanyar siginar JAK-STAT wanda ke watsa bayanai a waje da tantanin halitta a cikin kwayar halitta, yana rinjayar rubutun DNA.Kwanan nan an nuna shi a cikin samfurin murine na kafaffen arthritis, tofacitinib ya inganta cutar da sauri ta hanyar hana samar da masu shiga tsakani da kuma hana STAT1 masu dogara ga kwayoyin halitta a cikin haɗin gwiwa. Hanyoyi, suna ba da shawarar cewa tofacitinib na iya yin amfani da fa'idodin warkewa ta hanyoyin da ba su keɓance ga hana JAK3 ba.

Samfurin Samfura

图片418(1)
图片419(1)

Shirya samfur:

图片18

Ƙarin Bayani:

Abun ciki Saukewa: C16H20N6O
Assay 99%
Bayyanar Kashe-farar foda
CAS No. 477600-75-2
Shiryawa 25KG
Rayuwar Rayuwa shekaru 2
Adana Ajiye a wuri mai sanyi da bushewa
Takaddun shaida ISO.

  • Na baya:
  • Na gaba:

  • Ku rubuta sakonku anan ku aiko mana